Hiv Viral Load and Time-to-Covid-19 Vaccination among People Who Inject Drugs

Background: Structural barriers to care among people who inject drugs (PWID) raise concerns about disproportionate access to essential services like COVID-19 vaccination. Given the heightened risk of serious complications resulting from SARS-CoV-2 infection, particularly among people living with HIV (PWH) with unsuppressed viral load, its critical to understand the role of HIV care among other factors associated with timely vaccination. We aimed to assess the role of HIV care on COVID-19 vaccination uptake among PWID. Method(s): We included 960 adult PWUD participating in the ALIVE (AIDS Linked to the Intravenous Experience) longitudinal study in Baltimore, Maryland, who were alive and in follow up as of April 2020. We ed COVID-19 vaccination data from electronic medical records linked to participants via the regional health information exchange. We conducted survival analysis to estimate time from broad vaccine eligibility (April 6, 2021) to completion of the COVID-19 vaccination primary series by HIV status (uninfected, virally suppressed PWH [HIV-RNA< 400 copies/mL], unsuppressed PWH [HIV-RNA >400 copies/mL]) and Cox Proportional Hazards regression to adjust for potential confounding by health status and substance use variables. Result(s): Our sample (N=960) was primarily black (77%) and male (65%) with 31% reporting recent injection drug use. Among 265 people living with HIV (PWH) in our sample (27%), 84% were virally suppressed. As of February 22, 2022, 539 (56%) completed the primary series, 131 (14%) received a single dose of mRNA vaccine and 290 (30%) remained unvaccinated. Compared to PWID without HIV, virally suppressed PWH were significantly more likely to complete the primary series (Adjusted Hazard Ratio [AHR]:1.23,95% Confidence Interval [95%CI]:1.07,1.50), while PWH with higher viral loads were less likely (AHR:0.72,95%CI:0.45,1.16). Sensitivity analyses with a subsample restricted to PWH confirmed significant differences in time to vaccination by viral load status (log-rank p-value: 0.016) and modeling with an origin of Dec. 12, 2020, yielded similar adjusted results. Conclusion(s): Among PWID with HIV, viral suppression is associated with quicker vaccination uptake, likely due to HIV care engagement. Alongside interventions targeting social determinants (e.g. low income, homelessness) and substance use behaviors (e.g. active injecting, stimulant use), targeted improvements along the HIV care continuum and other efforts to engage PWID may bolster vaccine uptake. Figure 1. Kaplan-Meier survival curve demonstrating time-to-vaccination (completion of COVID-19 primary series) in weeks by HIV status accounting for viral load (HIV-, HIV+ [VL <= 400 cells/muL], HIV+ [VL > 400 cells/muL]), including results for Log-rank tests for homogeneity among strata (p-value).

Conference Proceedings 33rd AAAP Annual Meeting and Scientific Symposium

The proceedings contain 20 papers. The topics discussed include: the effect of specialty addiction consultation on prescribing medication for opioid use disorder (MOUD) during general hospital admission;mindfulness-based interventions for adolescent drug and alcohol use: a systematic review and meta-analysis;early changes in irritability predict longer-term abstinence from drug use in adults with stimulant use disorder: findings from the stride study;carfentanil, a highly potent opioid responding to high doses of naloxone, what can help?;an inpatient protocol for managing methamphetamine withdrawal;COVID-19 treatment outcome in a cohort of methamphetamine and cannabis users;the impact of COVID-19 on overdose risk and healthcare-seeking behaviors among hospitalized patients with opioid use disorder;and inpatient low dose transitions from full agonist opioids including methadone onto long-acting depot buprenorphine: case series from a multicenter clinical trial.

Polycythemia in a Pediatric Patient with Chronic Kidney Disease: Overuse of Erythropoetin During COVID-19 Isolation

We describe a case of a patient with Chronic Kidney Disease who developed polycythemia due to Erythropoiesis Stimulating Agents overuse during COVID-19 isolation. A 12-year-old male had not been able to attend routine controls since had been in isolation for 4 months after the COVID-19 outbreak. He had continued to take Erythropoiesis-Stimulating Agents during that period at the starting dose of 150 U/kg/week. He had been on peritoneal dialysis in the last year because of end-stage renal failure. Laboratory investigation revealed a hemoglobin (Hb) level of 20.8 g/dl, hematocrit level of 66%, creatinine level of 6.5 mgr/dl. He underwent daily phlebotomy sessions (10cc/kg/session). During this period aspirin was also started (5mg/kg). After 5 sessions his Hb level decreased to 14 gr/dl and hematocrit to 40%. Pediatric nephrologist should be aware that there is a potential risk of polycythemia with Erythropoiesis Stimulating Agents when Hb level is not appropriately followed on a routine basis. Copyright © 2021 Ankara Pediatric Hematology Oncology Training and Research Hospital. All rights reserved.

The Financial Services Authority's Regulation Function as a Bestuurshandeling Instrument for Economic Stimulation During a Pandemic

This paper has the purpose of investigating: (i) the justifications for the need for economic stimulus policies during the pandemic;and (ii) the role of OJK Regulation Number 11/POJK. 03/2020 as a bestuurshandeling instrumentation for boosting the economy during the epidemic. The government of Indonesia adopted the economic stimulation program as a strategy to improve the economy in response to the impact of the COVID-19 outbreak. As a result, it is worthwhile to investigate the policy parameters and act as a stimulant for the national economy. This study is normative in nature and was done through a document analysis using a statutory and conceptual framework. The study's findings show that: (i) the need for policies to stimulate the economy during a pandemic is driven by the necessity to fulfill the welfare state's role in light of the sociological conditions of the pandemic's impact on society, necessitating an economic stimulus policy instrument;and (ii) the function of OJK Regulation Number 11/POJK. 03/2020 as a bestuurshandeling instrumentation for strengthening the economy during a pandemic is a function of strengthening the economy through credit restructuring and being an indication through the economic risk management safety net.

A Weighty Matter:Quality Improvement Project in Pediatric Obesity During COVID-19 Pandemic at a Federally Qualified Health Center(FQHC)

Purpose/Objectives: Understand the rates of pediatric obesity in the Inland Empire of Southern California, in the context of COVID quarantine, to improve counseling and treatment of these patients. Design/Methods: A retrospective chart review was performed on all patients seen at a FQHC in Southern California. Patients between 5 and 18, who had a clinic visit between 6/1/2020 to 7/31/2020 for a well-child visit, with at least one other well-child visit in calendar year 2019 and 2018 were included. Patients with congenital heart disease, short gut syndrome, ADHD on stimulant medications, G tube dependence, diseases affecting growth or stature, complex syndromes (CHARGE, VACTERL, DiGeorge), syndromes affected growth, oncologic conditions, intellectual disability, transplant recipients, incomplete BMI data or malnutrition (BMI Z score <= -1) were excluded. BMI values, Z-scores, and percentiles, as well as relative changes from 2018 to 2019, and 2019 to 2020 were analyzed using one-way ANOVA and Tukey post hoc test. Results: There was a statistical difference in BMI between years as determined by a one-way ANOVA (F(2,509) = 2.811, P = 0.05). A Tukey post hoc test revealed that the BMI of students in 2020 was statistically higher (19.87.65, p = 0.05) compared to the BMI in 2018 (18.25.71). There was no statistical difference in BMI between 2020 and 2019, and 2019 and 2018 (Figure 1). When groups were stratified into morbidly obese (BMI >= 99%), obese (BMI >=95% & <99%), overweight (BMI >=85% & <95%), and healthy weight (BMI >=5% & < 85%), patients who were not at a healthy weight increased from 36.8% in 2018 to 40.4% in 2019, to 44.7% in 2020 (Figure 2). As shown in the SANKEY diagram (Figure 3), while there was an initial decline in morbidly obese patients in 2018 to 2019 (-8.3%), there was a relatively large increase from 2019 to 2020 (+45.5%). From 2018 to 2019, 75 out of 141 patients (53.2%) had a decrease in BMI, while in 2019 to 2020 there were 56 out of 141 patients (39.7%) who had a decrease in BMI. Out of the 75 patients who had a decrease in BMI from 2018 to 2019, 49 (65.3%) had a rebound increase in BMI from 2019 to 2020. Conclusion/Discussion: There was a significant increase in overall BMI from 2018 to 2020 with an overall increase in patients who fall into the obese and overweight categories in 2020. 65.3% of patients who had a decreasing BMI from 2018 to 2019 have a rebound increase in BMI in 2020. This can likely be contributed to the COVID-19 pandemic and stay-at-home orders leading to a more sedentary lifestyle. More research should be performed to elicit multifactorial (physical activity, diet, and psychosocial factors) etiology of the worsening obesity epidemic during the COVID-19 pandemic.

MANAGEMENT OF METHAMPHETAMINE INDUCED PNEUMONITIS

CASE: A 35-year-old female with history of pulmonary coccidiomycosis s/p treatment 15 years ago, ex-smoker who quit 8 years ago, unvaccinated for COVID-19 presented with two weeks of progressively worsening shortness of breath, fever, chills, generalized body aches, sore throat with hoarseness of voice, nonproductive cough, wheezing and midsternal chest pain. Denied sick contacts, recent travel, allergies or bird contact. On presentation, vitals were significant for hypoxia with SpO2 84% requiring 2L of nasal canula, sinus tachycardia to 109, tachypneic in 30s. Physical exam showed stridor and bilateral diffuse expiratory wheezing. Stridor improved with racemic epinephrine and dexamethasone 10mg IV. CBC, CMP, Procalcitonin, BNP, COVID-19 and Respiratory PCR were negative, while coccidioidomycosis antibody was positive. UDS was positive for methamphetamine. Chest X-ray showed features of atypical pneumonitis. CT Chest showed similar findings and was negative for pulmonary embolism. She was managed symptomatically with albuterol inhaler. Respiratory symptoms improved during hospitalization without any further interventions. IMPACT/DISCUSSION: Methamphetamine can cause toxic lung parenchyma injury irrespective of frequency of use. With recent increase in use of methamphetamine, paucity of literature and unclear mechanism in lung injury, it is important for physicians to be aware of methamphetamine associated lung injury as a differential diagnosis of acute/subacute respiratory distress with the risk factors of illicit drug use in the era of COVID pandemic. According to National Survey on Drug Use and Health (NSDUH) in 2018, 1.6 million people (age > 26 years) used methamphetamine in one year which is 0.5% more than 2016-2017. Crystalline methamphetamine is a widely used inhaled stimulant with few reported cases of acute respiratory distress syndrome, eosinophilic pneumonia, pneumonitis, and diffuse alveolar hemorrhage. Even though the mechanism of injury is unclear in human beings, toxicity was studied in animals. Chronic methamphetamine use causes thickened alveolar walls and reduced alveolar sacs by oxidative stress and by increased free radical formation. Patients often present with non-specific symptoms including cough, shortness of breath, sore throat or chest pain. The temporal relation of symptomatology with methamphetamine use and exclusion of infectious and other pulmonary etiology based on labs and radiological findings are crucial in establishing the diagnosis. Early diagnosis, symptomatic treatment and cessation of substance use are core management. CONCLUSION: We discussed a case of methamphetamine-induced pneumonitis, who presented with upper and lower respiratory symptoms that resolved dramatically with the early diagnosis and supportive care. We recommend considering methamphetamine-induced lung injury as a differential diagnosis in patients with risk factors of illicit drug use, especially in the era of the COVID-19 pandemic for early diagnosis and appropriate management.

Thyroid Storm Presenting as Acute Decompensated Biventricular Heart Failure in a Young Male

Introduction: Thyroid storm (TS) is a rare and life-threatening condition that carries an extremely high mortality rate up to 20% when treated and 100% if untreated. TS can have a variety of presentations, but it most commonly occurs with altered mentation, cardiovascular dysfunction, thermoregulatory dysfunction and at times gastrointestinal or hepatic dysfunction. TS can develop in patients who have long-standing untreated hyperthyroidism and is usually precipitated by an acute inciting event such as an infection, medication, or trauma. This is a case of TS that presented with atypical features in a young man. Early recognition of TS lead to successful treatment of his severe thyrotoxicosis and acute heart failure. Case Description: A 32-year-old Haitian male with a history of ADHD, insomnia, and family history of cardiomyopathy, presented to the ED with 6-months of progressive shortness of breath, palpitations, and exertional chest pain following Covid-19 illness in his household, noting he was unable to donate blood due to tachycardia but was asked to return and donate plasma. In the last month he experienced intermittent symptoms of orthopnea, tremors, fevers, night sweats, diarrhea, anxiety, and severe fatigue for which his stimulant medication was increased to twice daily and for insomnia quetiapine dosage was increased. He works in landscaping and was unable to perform his usual labor duties due to progressive fatigue and dyspnea. Initial vital signs were temperature of 37.2ºC, sinus tachycardia at 130bpm, BP 118/73, tachypneic RR 21 with SpO2 99% on room air. On exam he had orthopnea, diaphoresis, scleral icterus, S3 gallop, bibasilar crackles, and hyperreflexia. He was admitted for acute decompensated heart failure with echocardiogram findings of ejection fraction 15-20% and grade 3 diastolic dysfunction with deep trabeculations as seen in noncompaction cardiomyopathy and BNP of 1200. Thyroid studies indicated thyrotoxicosis with undetectable TSH, high Free T4 (3.62 ng/dL), T3 (7.25 pg/ml), and high TSH receptor antibodies (5.08 IU/L). Covid-19 PCR was negative, and Lyme IgM was positive. His clinical condition was consistent with thyroid storm per Burch-Wartofsky Point Scale (BWPS). Using precise clinical criteria his score was 55;a score over 45 is highly suggestive of TS. He was managed with propylthiouracil (PTU), iodine, glucocorticoids, propranolol, and cholestyramine until Free T3 and Free T4 normalized. Discussion: Thyroid storm is important to recognize and diagnose in patients with symptoms of thyrotoxicosis. The etiology of this patient’s acute decompensated biventricular heart failure was thyroid storm with likely underlying familial cardiomyopathy, worsened by chronic undiagnosed hyperthyroidism, medication, COVID-19, or Lyme disease. The calculation of BWPS score, using precise clinical criteria, was essential in the recognition of thyroid storm. This patient significantly improved with the proper treatment protocol of TS due to Graves’ disease. In the era of the Covid-19 pandemic, this case can highlight a possible severe sequela of this viral illness including thyrotoxicosis and acute heart failure in a young patient.